MedPath

Optimal treatment of steroid sensitive nephrotic syndrome in children.

Completed
Conditions
-children with the initial episode or five or less relapses will be included-only children with a history of an idiopathic NS/MCNS will be included
Registration Number
NL-OMON27512
Lead Sponsor
Dutch Kidney Foundation
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
150
Inclusion Criteria

1. Children from 9 months up to 16 years will be included;

2. Only children with idiopathic nephrotic syndrome will be included.

Exclusion Criteria

1. Children with nephrotic syndrome due to a specific disease;

2. Children with more than five relapses;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
umber of patients with frequent relapses.
Secondary Outcome Measures
NameTimeMethod
umber of patients with sustained remission.<br>Adverse effects of prednisolone.<br>Cumulative dose op prednisolone during follow up.<br>
© Copyright 2025. All Rights Reserved by MedPath